Back to assets

Vertex Pharmaceuticals Incorporated

(VRTX)
$515.02 -5.64 (-1.08%)
Daily Range 513.87 - 531.37
52 wk Range 412.27 - 568.67
Vertex Pharmaceuticals Incorporated (VRTX) $515.02 -5.64 (-1.08%)
USD · ET

Key Statistics

Analyst Ratings

  • Hold 7
  • Sell 1
  • Buy 48

Ratings: 56 analysts

Overall Consensus

Buy

Analysts 12-Month Price Target:

Average $579.29 (+12.48% Upside)

FirmPositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Cantor FitzgeraldOverweight$619.00+20.19%$595.00maintainNov 3, 2026
Wells FargoOverweight$650.00+26.21%$460.00maintainNov 3, 2026
Cowen & Co.Buy$575.00+11.65%—maintainNov 3, 2026
RBC CapitalOutperform$576.00+11.84%$570.00maintainOct 8, 2026
UBSBuy$615.00+19.41%$585.00maintainSep 28, 2026

Vertex Pharmaceuticals Incorporated News & Analysis

View All

The Prepaid Debit Visa Card (the “Card”) is issued by Lead Bank pursuant to licensing by Visa U.S.A. Inc. and may be used everywhere Visa is accepted. Must be 18 or older to apply. Fees may apply. See Cardholder Agreement and defi.com website for more details.

Bridge Ventures LLC (“Bridge”) is not a bank. Bridge is a financial technology company and is the Program Manager responsible for managing and operating the Card on behalf of Lead Bank. defi.com is not a bank. defi.com is a financial technology company and is the Platform Provider responsible for the application, access, and management of/for the card.